This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Limin Cheng
Introduction
Limin Cheng, an accomplished inventor based in Beijing, China, has made significant strides in the field of pharmaceuticals. With a focus on developing novel compounds, his work has implications for treating various diseases through innovative methodologies.
Latest Patents
Limin Cheng holds a patent for "Pyrazolopyrimidine compounds and methods of use thereof." This patent encompasses compounds of Formula (IA), or pharmaceutically acceptable salts, and details their use as Janus kinase inhibitors, highlighting the potential for therapeutic applications.
Career Highlights
Currently, Cheng is employed at Genentech, Inc., a leading biotechnology company dedicated to advancing medical science through innovation. His expertise and research have contributed to the company’s efforts in developing groundbreaking treatments.
Collaborations
Throughout his career, Limin Cheng has collaborated with esteemed colleagues such as F Anthony Romero and Mark Edward Zak. These partnerships have fostered a rich environment for creativity and innovation, furthering advancements in their respective fields.
Conclusion
Limin Cheng's inventive spirit and dedication to pharmaceutical research exemplify the essence of innovation in modern science. Through his accomplishments, he continues to inspire the next generation of inventors and researchers in the quest for groundbreaking solutions to health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile